Skip to content
mapperlab
← Dashboard
Stock

LH

LABCORP HOLDINGS INC.
Health CareHealth Care ServicesLatest close $2566 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
6
27 funds tracked
Ever held
8
Current + past
New this quarter
1
Exited this quarter
0

Marquee-fund ownership over time

Aug 14, 2024Nov 14, 2024Aug 14, 2025May 15, 2026
Now
6

This quarter's activity

New positions opened

Positions exited

None.

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates$216$256+18%
AQR Capital Management$217$256+18%
Millennium Management$217$256+18%
Citadel Advisors$234$256+9%
Point72 Asset Management re-entered$244$256+5%
Maverick Capital$265$256-3%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
D.E. Shaw→ $269+24%
Renaissance Technologies→ $242-0%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at LABCORP HOLDINGS INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
2
Filings · last 90d
14
Total on file
589
Recent SEC buffer
Most recent
Jun 10, 2026

30d / 90d windows measured from Jun 10, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 589 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · LABCORP HOLDINGS INC.

Annual figures sourced directly from LABCORP HOLDINGS INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$13.95B
FY2025+7% YoY
Net income
$876.5M
FY2025+17% YoY
EPS (diluted)
$10.46
FY2025+18% YoY
Free cash flow(?)
$1.21B
FY2025+10% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for LABCORP HOLDINGS INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Point72 Asset ManagementQ2 2026open$250$256+2%
Maverick CapitalQ4 2025open$265$257-3%
Point72 Asset ManagementQ2 2025Q3 2025$244$269+10%
Citadel AdvisorsQ4 2024open$234$256+9%
Renaissance TechnologiesQ4 2024Q1 2025$242$242-0%
Bridgewater AssociatesQ3 2024open$216$257+19%
D.E. ShawQ3 2024Q3 2025$217$269+24%
AQR Capital ManagementQ3 2024open$217$256+18%
Millennium ManagementQ3 2024open$217$256+18%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.